Evidence map›Paper›PMID 12358435›Full record

ArticleRNA (New York, N.Y.)2002

Targeting a KH-domain protein with RNA decoys.

Aleksandr V Makeyev, Dawn L Eastmond, Stephen A Liebhaber

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. P-element Somatic Inhibitor Protein Binding a Target Sequence inInternational journal of molecular sciences · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Effects of local mRNA structure on posttranscriptional gene silencing.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aleksandr V MakeyevDepartment of Genetics, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.
Dawn L Eastmond
Stephen A Liebhaber
University of Pennsylvania · US

Funding

VAV ANTISENSE ODN--A NOVEL THERAPEUTIC FOR HUMAN LEUKEMIASP01CA072765 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GEWIRTZ, ALAN M · 1997 to 2007
$8.5M
Post-Transcriptional controls in Mammalian Erythroid DifferentiationR01HL065449 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LIEBHABER, STEPHEN AARON · 2000 to 2019
$4.1M
Alpha-Globin expression: Post transcriptional mechanismsR37HL065449 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LIEBHABER, STEPHEN AARON · 2004 to 2013
$3.9M
NCI NIH HHS P01-CA72765NHLBI NIH HHS R01-HL 65449NHLBI NIH HHS R37 HL065449
6 · The paper itself

Abstract

RNA-binding proteins are involved in the regulation of many aspects of eukaryotic gene expression. Targeted interference with RNA-protein interactions could offer novel approaches to modulation of expression profiles, alteration of developmental pathways, and reversal of certain disease processes. Here we investigate a decoy strategy for the study of the alphaCP subgroup of KH-domain RNA-binding proteins. These poly(C)-binding proteins have been implicated in a wide spectrum of posttranscriptional controls. Three categories of RNA decoys to alphaCPs were studied: poly(C) homopolymers, native mRNA-binding sites, and a high-affinity structure selected from a combinatorial library. Native chemistry was found to be essential for alphaCP decoy action. Because alphaCP proteins are found in both the nucleus and cytoplasm, decoy cassettes were incorporated within both nuclear (U1 snRNA) and cytoplasmic (VA1 RNA) RNA frameworks. Several sequences demonstrated optimal decoy properties when assayed for protein-binding and decoy bioactivity in vitro. A subset of these transcripts was shown to mediate targeted inhibition of alphaCP-dependent translation when expressed in either the nucleus or cytoplasm of transfected cells. Significantly, these studies establish the feasibility of developing RNA decoys that can selectively target biologic functions of abundant and widely expressed RNA binding proteins.

Indexed as

DNA-Binding ProteinsHeterogeneous-Nuclear RibonucleoproteinsTranscription FactorsAnimalsBase SequenceBinding SitesCarrier ProteinsDrug DesignGene ExpressionGenetic VectorsHeLa CellsHumansIn Vitro TechniquesLuciferasesMiceMolecular Sequence DataCarrier ProteinsDNA-Binding ProteinsHeterogeneous-Nuclear RibonucleoproteinsLuciferasesPcbp1 protein, mouseRecombinant ProteinsRibonucleoproteinsRNARNA-Binding ProteinsTranscription Factors

Identifiers

PMID12358435
PMCPMC1370330
OpenAlexW2096095309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.